Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Phytomedicine ; 6(5): 311-7, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11962536

RESUMO

Hypericin and hypocrellin are potential antiviral and antineoplastic agents with multiple modes of light-induced biological activity connected with a production of singlet oxygen and/or excited-state proton transfer and consequent pH drop formation in the drugs environment. In present work light-induced cytotoxicity of hypericin (1 x 10(-5) - 10(-9) mol) and hypocrellin (1 x 10(-5) - 10(-9) mol) and potentiating effect of omeprazole on human leukemic cell line HL-60 was studied. Under dark condition cultivation none cytotoxicity was observed. The only one exception was hypocrellin in concentration 1 x 10(-5) mol which displayed full cytotoxic effect. However, illumination increased cytotoxic effect of hypericin and hypocrellin, both. Omeprazole, an inhibitor of H+K+-ATPase, has been used for testing the hypothetical pH decreasing effect of hypericin and hypocrellin in their cytotoxic mechanism of action. The results of our experiments have shown that in HL-60 cell line the effect of hypericin and hypocrellin at 1 x 10(-6) mol (both) was significantly potentiated by omeprazole in concentrations 1 x 10(-6) - 10(-9) mol. Our results support the hypothesis that the excited-state proton transfer and the consequent acidification of hypericin and hypocrellin environment could play a role in the biological activity of both agents.


Assuntos
Omeprazol/farmacologia , Perileno/análogos & derivados , Perileno/farmacologia , Fármacos Fotossensibilizantes/farmacologia , Quinonas/farmacologia , Antracenos , Antineoplásicos/agonistas , Antineoplásicos/farmacologia , Antivirais/agonistas , Antivirais/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Sinergismo Farmacológico , Células HL-60 , Humanos , Perileno/agonistas , Fenol , Fármacos Fotossensibilizantes/agonistas , Quinonas/agonistas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...